This week in gene and cell therapy - 8 March 2019

Gene and cell therapy headlines 4 - 8 March

Biogen enters ophthalmology gene therapy field with Nightstar takeover

Roche becomes a major gene therapy player with the acquisition of Spark Therapeutics

Targetgin Nr4a transcription factors a possible strategies for combatting CAR-T cell exhaustion in solid tumour treatment

Second patient HIV free after stem cell transplant: renewed interest in gene therapies targeting CCR5?

Gilead and MaxCyte expand CAR-T partnership

Orchard presents encouraging follow up data of trial of stem cell gene therapy for ADA-SCID

Autolus partners with software company Veneti to make production and delivery of CAR-T cell therapies more efficient

BioPharm partners with Trinity College Dublin to develop cell-based cancer treatments